Regulatory Risk Focus CIS by Deloitte specializes in integrated compliance and risk mitigation for life sciences and health care, presenting a sales opportunity to offer end-to-end compliance infrastructure, risk assessments, and remediation programs to mid-market pharma and biotech firms seeking to strengthen regulatory controls.

MSO Value Proposition Their Managed Services Operations deliver a technology-driven, SaaS-based approach to guide commercial strategies, suggesting a sales path for clients seeking ongoing optimization of sales and commercialization processes with scalable platform and ongoing support.

Low to Mid Revenue Target With annual revenue in the 1–10 million range and a relatively small employee base, there is a growth opportunity to upsell advanced compliance automation, analytics, and advisory services to emerging life sciences companies scaling their commercial operations.

Industry Alignment Positioned to serve life sciences and health care, a cross-sell opportunity exists with large professional services firms as potential partners or referral sources, leveraging CIS by Deloitte’s advisory capabilities to broaden client engagements in regulatory, risk, and commercial strategy segments.

Technology-Driven Offering Emphasize expanding the technology stack in services like SaaS-based compliance and commercial optimization, appealing to firms prioritizing digital transformation, data-driven decision making, and scalable governance across business lines.